Management of the cirrhotic patient that needs surgery
Tóm tắt
Conditions that necessitate surgery frequently arise in patients with chronic liver disease and cirrhosis. Because cirrhosis has the ability to cause physiologic derangements in every organ system in the body, clinicians face significant challenges in preoperative preparation of the patient with cirrhosis in order to decrease postoperative morbidity and mortality. Emergent operations add an extra dimension of complexity to the clinical picture, due to limited preoperative time to prepare the patient with cirrhosis for surgery. In cases of severely decompensated cirrhosis, clinicians should have in their armamentarium possible alternatives to surgery that can be used to temporize the emergent nature of the disease and improve patient outcomes. The classification of cirrhotic liver disease by Child and Turcotte was initially utilized to predict mortality in patients undergoing surgically placed shunts for portal hypertensive bleeding. Subsequent studies have pointed to the fact that other general and thoracic surgery procedures can be assigned predicted mortality rates according to a similar classification scheme, the modified Child-Pugh score. Patients with cirrhosis facing surgery should undergo a careful history and physical examination and should be accurately placed into a designated Child-Pugh category. Because the modified Child-Pugh class is the most reliable determinant of postoperative morbidity and mortality, every attempt should be made to upgrade a patient’s class in a favorable direction prior to surgery. Patients should be carefully evaluated for the presence of ascites and dietary alterations. In addition, medical management with diuretics should be employed to prevent postoperative ascites leak and possible infectious complications including bacterial peritonitis. Perhaps one of the most feared complications in the patient with cirrhosis facing surgery is hemorrhage. Because the liver is vital in maintenance of coagulation homeostasis, several pharmacologic adjuncts may be administered to correct any coagulopathy in the peri-operative period. Several diseases such as cholelithiasis and peptic ulcer disease are known to be more prevalent in the cirrhotic patient, and clinicians treating these diseases should have a thorough understanding of the pathophysiology of cirrhosis and portal hypertension. Patients with cirrhosis and portal hypertensive bleeding that are considered good surgical candidates (ie, Child-Pugh class A) may benefit from surgical portasystemic shunt in contrast to angiographically placed portacaval shunt (ie, transjugular intrahepatic portosystemic shunt [TIPS]) due to the lack of durable patency and cost effectiveness in the latter. In patients with cirrhosis awaiting orthotopic liver transplantation, TIPS may be a lifesaving temporizing technique that is utilized as a bridge to transplantation.
Từ khóa
Tài liệu tham khảo
Wiklund RA: Preoperative preparation of patients with advanced liver disease. Crit Care Med 2004, 32: 106S-115S. This paper describes steps for optimal preparation of the patient with liver disease who is undergoing surgery.
Rizvon MK, Chou CL: Surgery in the patient with liver disease. Med Clin N Am 2003, 87: 211–227. This paper reviews the management of patients with cirrhosis and other types of liver disease who are facing surgery.
Patel T: Surgery in the patient with liver disease. Mayo Clin Proc 1999, 74: 593–599. This paper outlines the preoperative approach in patients with known or suspected liver disease.
Child CG III, Turcotte JG: Surgery and portal hypertension. Major Probl Clin Surg 1964, 1: 1–85.
Farnsworth N, Fagan SP, Berger DH, Awad SS: Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surgery 2004, 188: 580–583.
Befeler AS, Palmer DE, Hoffman M, et al.: The safety of intra-abdominal surgery in patients with cirrhosis. Arch Surg 2005, 140: 650–655.
Gill RA, Goodman MW, Golfus GR: Aminopyrine breath test predicts surgical risk for patients with liver disease. Ann Surg 1983, 198: 701–704.
Mansour A, Watson W, Shayani V, Pickleman J: Abdominal operations in patients with cirrhosis: still a major surgical challenge. Surgery 1997, 122: 730–736. This important paper addresses the outcomes of cirrhotics undergoing general surgical procedures and emphasizes the importance of assigning Child’s class in predicting complication rates.
Garrison RN, Cryer HM, Howard DA, Polk HC Jr: Clarification of risk factors for abdominal operations in patients with hepatic cirrhosis. Ann Surg 1984, 199: 648–655.
Doberneck RC, Sterling WA Jr, Allison DC: Morbidity and mortality after operation in nonbleeding cirrhotic patients. Am J Surg 1983, 146: 306–309.
Friedman LS: The risk of surgery in patients with liver disease. Hepatology 1999, 29: 1617–1623. This paper outlines risk factors for complications postoperatively and reviews topics such as resection for hepatocellular carcinoma and the approach for obstructive jaundice in the cirrhotic patient.
Florez DA, Aranda-Michel J: Nutritional management of acute and chronic liver disease. Seminars in Gastrointestinal Disease 2002, 13: 169–178.
Hernandez V, Pascual I, Almela P, et al.: Recurrence of acute gallstone pancreatitis and relationship with cholecystectomy or endoscopic sphincterotomy. Am J Gastroenterology 2004, 99: 2417–2423.
Kaw M, Al-Antably Y, Kaw P: Management of gallstone pancreatitis: cholecystectomy or ERCP and endoscopic sphincterotomy. Gastrointestinal Endoscopy 2002, 56: 61–65.
Fernandes NF, Schwesinger WH, Hilsenbeck SG, et al.: Laparoscopic cholecystectomy and cirrhosis: a casecontrol study of outcomes. Liver Transplantation 2000, 6: 340–344.
Wu CC, Yeh DC, Lin MC, Liu TJ, P’eng FK: Improving operative safety for cirrhotic liver resection. Br J Surg 2001, 88: 210–215.
Klemperer JD, Wilson K, Krieger KH, et al.: Cardiac operations in patients with cirrhosis. Ann Thorac Surg 1998, 65: 85–87.
Helton WS, Maves R, Wicks K, Johansen K: Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients. Arch Surg 2001, 136: 17–20.
Zacks SL, Sandler RS, Biddle AK, Mauro MA, et al.: Decision-analysis of transjugular intrahepatic portosystemic shunt versus distal splenorenal shunt for portal hypertension. Hepatology 1999, 29: 1399–1405.